To determine whether AML generated in vivo from Trib2 overexpression similarly led to a chemoresistant profile, we studied the effect of drug treatment (Ara-C, Dox/DNR and etoposide) on AML cell viability. Here, TRIB2 is linked to acute myeloid leukemia.